http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1144309-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a12b0be1b74901f556d1d1a9200529ce
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K11-778
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K11-7712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B35-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K11-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B35-12
filingDate 1999-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fa7baba17e33cb5f4a3895ad58471d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5513864c1d36404a61723e4b9a56a41
publicationDate 2002-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1144309-A3
titleOfInvention Lanthanum, lutetium, yttrium or gadolinium borate comprising two doping agents and its precursor, use in plasma or x-ray systems
priorityDate 1998-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13908713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454397678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136068

Total number of triples: 28.